Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist

By Navari Rudolph M  

Future Oncology, Vol. 2, Iss. 5, 2006-10 ,pp. : 591-602

Future Medicine

Access to resources Recommend Favorite

The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting

By                    

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1418-1426

Spandidos Publications

Access to resources Recommend Favorite

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer

By Navari Rudolph M  

Future Oncology, Vol. 6, Iss. 7, 2010-07 ,pp. : 1073-1084

Future Medicine

Access to resources Recommend Favorite

Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population

By Tian Weihua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 71-78

Humana Press, Inc

Access to resources Recommend Favorite

Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracyclinebased regimens

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 119-124

Spandidos Publications

Access to resources Recommend Favorite